A longitudinal evaluation of dexamethasone pharmacokinetics in depressed patients and normal controls.
Ten depressed patients and eight control subjects received 1 mg of dexamethasone intravenously at two different time points. Depressed patients were studied when they were depressed and following an improvement in their depression. In control subjects the first and second studies were performed approximately 1 month apart. Dexamethasone and cortisol were determined at 0, 5, 15, and 30 minutes, then at 1, 1.2, 2, 3, 4, 5, 6, 7, 9, 12, 17, and 24 hours following dexamethasone administration. Data from each patient was fit using a computer to a two compartment pharmacokinetic model and area under the time versus plasma concentration curve, elimination half-life, and clearance were also determined. Depressed patients exhibited a slower dexamethasone clearance and a larger area under the curve than control subjects at the first time point, but not at the second time point. The groups did not differ significantly in any of the other pharmacokinetic parameters (including distribution half-life, elimination half-life, or volume of distribution) at either time point. The possible causes and implications of these findings are discussed.
Guthrie
S K
SK
College of Pharmacy, University of Michigan, Ann Arbor 48109-1065.
Heidt
M
M
Pande
A
A
Grunhaus
L
L
Haskett
R F
RF
Hariharan
M
M
D000328:Adult; D003866:Depressive Disorder / Q000378:metabolism* / Q000523:psychology; D003907:Dexamethasone / Q000493:pharmacokinetics*; D005260:Female; D006207:Half-Life; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D011569:Psychiatric Status Rating Scales
D003907:Dexamethasone; D006854:Hydrocortisone